CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells

Michelle L Hermiston1, Julie Zikherman, Jing W Zhu

  • 1Department of Pediatrics, University of California, San Francisco, CA 94143, USA. HermistonM@peds.ucsf.edu

Immunological Reviews
|March 18, 2009
PubMed

Insights

Protein tyrosine phosphatases (PTPs) like CD45, CD148, and LYP/PEP regulate Src family kinases (SFKs) in immune cells. Dysregulation of these PTPs impacts immune function and disease, highlighting therapeutic potential.

Area of Science:

  • Immunology
  • Cell Signaling
  • Biochemistry

Background:

  • Tyrosine phosphorylation, regulated by protein tyrosine kinases (PTKs) and phosphatases (PTPs), is crucial for immune cell function.
  • Imbalances in PTK/PTP activity are linked to immunodeficiency, autoimmunity, and malignancy.
  • Src family kinases (SFKs) are key mediators in signaling pathways activated by various immune receptors.

Purpose of the Study:

  • To review the roles of CD45, CD148, and LYP/PEP phosphatases in regulating SFKs in hematopoietic cells.
  • To discuss their structures, expression, functions, regulation, and involvement in disease.
  • To identify knowledge gaps and therapeutic opportunities in regulating tyrosine phosphorylation in immune cells.

Main Methods:

  • Literature review focusing on CD45, CD148, and LYP/PEP.
  • Analysis of their roles in hematopoietic cell signaling.
  • Discussion of their involvement in immune-related diseases.

Main Results:

  • CD45, CD148, and LYP/PEP are critical regulators of SFKs in various immune cell subsets.
  • These phosphatases influence signaling cascades initiated by immune receptors.
  • Their dysregulation is implicated in immune disorders.

Conclusions:

  • Understanding the coordinated regulation of SFKs by these PTPs is essential for comprehending immune cell signaling.
  • Targeting these phosphatases may offer therapeutic strategies for immune-related diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...